STOCK TITAN

Endava Announces Second Quarter Fiscal Year 2021 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Endava plc (NYSE: DAVA) reported strong Q2 FY2021 results, achieving £105.2 million in revenue, a 22.5% year-on-year increase. The profit before tax reached £10.6 million, reversing a loss of £(17.3) million from the previous year largely due to a one-time bonus. Adjusted profit before tax was £20.6 million (19.6% of revenue). Cash flow from operations improved to £20.4 million. For Q3 FY2021, revenue guidance is £110.0 to £111.5 million, indicating 20.0% to 21.5% growth, while full-year revenue guidance stands at £423.0 to £426.0 million.

Positive
  • Q2 FY2021 revenue grew by 22.5% to £105.2 million.
  • Profit before tax of £10.6 million compared to a loss of £(17.3) million in the prior year.
  • Adjusted profit before tax was £20.6 million (19.6% of revenue).
  • Cash flow from operations improved to £20.4 million.
  • Revenue guidance for Q3 FY2021 is £110.0 to £111.5 million.
Negative
  • Adjusted profit margin decreased to 19.6% from 23.8% year-on-year.
  • Cash and cash equivalents declined from £101.3 million at June 30, 2020, to £84.2 million.

Endava plc (NYSE: DAVA) ("Endava" or the "Company") a global provider of digital transformation, agile development and intelligent automation services, today announced results for the three months ended December 31, 2020, the second quarter of its 2021 fiscal year ("Q2 FY2021").

"Endava delivered another strong quarter with revenue for Q2 FY2021 of £105.2 million, an increase of 22.5% Year on Year. Demand for digital transformation remains unabated, and we continued to broaden our client base during the quarter," said John Cotterell, Endava's CEO.

SECOND QUARTER FISCAL YEAR 2021 FINANCIAL HIGHLIGHTS:

  • Revenue for Q2 FY2021 was £105.2 million, an increase of 22.5% compared to £85.9 million in the same period in the prior year.
  • Revenue growth rate at constant currency (a non-IFRS measure) was 21.4% for Q2 FY2021 compared to 20.5% in the same period in the prior year.
  • Profit before tax for Q2 FY2021 was £10.6 million compared to loss before tax of £(17.3) million in the same period in the prior year. The loss during the same period in the prior year was the result of the declaration of a non-recurring, discretionary employee bonus, which is referred to as the "discretionary EBT Bonus," of £27.7 million in December 2019.
  • Adjusted profit before tax (a non-IFRS measure) for Q2 FY2021 was £20.6 million, compared to £20.5 million in the same period in the prior year, or 19.6% of revenue, compared to 23.8% of revenue in the same period in the prior year.
  • Profit for the period was £7.8 million in Q2 FY2021, resulting in a diluted EPS of £0.14, compared to loss for the period of £(13.8) million and diluted EPS of £(0.25) in the same period in the prior year.
  • Adjusted profit for the period (a non-IFRS measure) was £16.4 million in Q2 FY2021, resulting in adjusted diluted EPS (a non-IFRS measure) of £0.29 compared to adjusted profit for the period of £16.8 million and adjusted diluted EPS of £0.30 in the same period in the prior year.

CASH FLOW:

  • Net cash from operating activities was £20.4 million in Q2 FY2021 compared to £11.1 million in the same period in the prior year.
  • Adjusted free cash flow (a non-IFRS measure) was £18.7 million in Q2 FY2021 compared to £8.0 million in the same period in the prior year.
  • At December 31, 2020, Endava had cash and cash equivalents of £84.2 million, compared to £101.3 million at June 30, 2020.

OTHER METRICS FOR THE QUARTER ENDED DECEMBER 31, 2020:

  • Headcount (including directors) reached 7,464 at December 31, 2020, with 6,629 average operational employees in Q2 FY2021, compared to a headcount of 6,267 at December 31, 2019 and 5,472 average operational employees in the same quarter of the prior year.
  • Number of clients with over £1 million in revenue on a rolling twelve months basis was 75 at December 31, 2020, compared to 65 at December 31, 2019.
  • Top 10 clients accounted for 37% of revenue in Q2 FY2021, unchanged compared to December 31, 2019.
  • By geographic region, 29% of revenue was generated in North America, 27% was generated in Europe, 42% was generated in the United Kingdom and 2% was generated in the rest of the world in Q2 FY2021. This compares to 29% in North America, 23% in Europe, 45% in the United Kingdom and 3% in the rest of the world in the same period in the prior year.
  • By industry vertical, 49% of revenue was generated from Payments and Financial Services, 28% from TMT and 23% from Other. This compares to 53% from Payments and Financial Services, 24% from TMT and 23% from Other in the same period in the prior year.

OUTLOOK:

At this time, the general economic environment remains fluid and it continues to be challenging to anticipate the ultimate full scope and duration of the impact of the COVID-19 pandemic. Endava is providing guidance for the third quarter of its 2021 fiscal year and its full 2021 fiscal year based upon what it currently sees in its markets.

Third Quarter Fiscal Year 2021:

Endava expects revenues will be in the range £110.0 million to £111.5 million, representing constant currency revenue growth of between 20.0% and 21.5%. Endava expects adjusted diluted EPS to be in the range of £0.27 to £0.28 per share.

Full Fiscal Year 2021:

Endava expects revenues will be in the range £423.0 million to £426.0 million, representing constant currency growth of between 22.0% and 22.5%. Endava expects adjusted diluted EPS to be in the range of £1.10 to £1.13 per share.

The constant currency growth figure now quoted for the full fiscal year 2021 guidance is pro-forma for the sale of the Worldpay Captive, which Endava sold in August 2019 and still remains in the full year comparative.

This above guidance for Q3 Fiscal Year 2021 and the Full Fiscal Year 2021 assumes the exchange rates at the end of January (when the exchange rate was 1 British Pound to 1.37 US Dollar and 1.13 Euro).

Endava is not able, at this time, to provide an outlook for IFRS diluted EPS for Q3 FY2021 or FY2021 because of the unreasonable effort of estimating on a forward-looking basis certain items that are excluded from adjusted diluted EPS, including, for example, share-based compensation expense, amortisation of acquired intangible assets and foreign currency exchange (gains)/losses, the effect of which may be significant. Endava is also not able, at this time, to reconcile to an outlook for revenue growth not at constant currency because of the unreasonable effort of estimating foreign currency exchange gains/losses, the effect of which may be significant, on a forward-looking basis.

The guidance provided above is forward-looking in nature. Actual results may differ materially. See the cautionary note regarding “Forward-Looking Statements” below.

CONFERENCE CALL DETAILS:

The Company will host a conference call at 8:00 am EST today, February 17, 2021, to review its Q2 FY2021 results. To participate in Endava’s Q2 FY2021 earnings conference call, please dial in at least five minutes prior to the scheduled start time (833) 921-1651 or (778) 560-2811 for international participants, Conference ID 8574719.

Investors may listen to the call on Endava’s Investor Relations website at http://investors.Endava.com. The webcast will be recorded and available for replay until Friday, March 5, 2021.

ABOUT ENDAVA PLC:

Endava is a leading next-generation technology services provider and helps accelerate disruption by delivering rapid evolution to enterprises. Using distributed enterprise agile at scale, Endava collaborates with its clients, seamlessly integrating with their teams, catalysing ideation and delivering robust solutions. Endava helps its clients become digital, experience-driven businesses by assisting them in their journey from idea generation to development and deployment of products, platforms and solutions. It services clients in the following industries: Payments and Financial Services, TMT and "Other," which includes Consumer Products, Retail, Mobility and Healthcare. Endava had 7,464 employees (including directors) as of December 31, 2020 located in North America, Western Europe and Australia and delivery centres in Romania, Moldova, Bulgaria, Serbia, North Macedonia, Slovenia, Bosnia & Herzegovina, Argentina, Uruguay, Venezuela, and Colombia.

NON-IFRS FINANCIAL INFORMATION:

To supplement Endava’s Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets and Consolidated Statements of Cash Flow presented in accordance with IFRS, the Company uses non-IFRS measures of certain components of financial performance. These measures include: revenue growth rate at constant currency, revenue growth at constant currency adjusted for the sale of Endava Technology SRL, also referred to as “the Worldpay Captive” to Worldpay on August 31, 2019, adjusted profit before tax, adjusted profit for the period, adjusted diluted EPS and adjusted free cash flow.

Revenue growth rate at constant currency is calculated by translating revenue from entities reporting in foreign currencies into British Pounds using the comparable foreign currency exchange rates from the prior period. For example, the average rates in effect for the fiscal quarter ended December 31, 2019 were used to convert revenue for the fiscal quarter ended December 31, 2020 and the revenue for the comparable prior period.

Revenue growth at constant currency adjusted for the sale of the Worldpay Captive is revenue growth at constant currency adjusted to exclude the impact of the sale of the Worldpay Captive.

Adjusted profit before tax ("Adjusted PBT") is defined as the Company’s profit before tax adjusted to exclude the impact of share-based compensation expense, discretionary EBT bonus, amortisation of acquired intangible assets, realised and unrealised foreign currency exchange gains and losses, and net gain on disposal of subsidiary. Share-based compensation expense, amortisation of acquired intangible assets and unrealized foreign currency gains are non-cash expenses. Adjusted PBT margin is Adjusted PBT as a percentage of total revenue.

Adjusted profit for the period is defined as Adjusted PBT together with the tax impact of these adjustments.

Adjusted diluted EPS is defined as Adjusted profit for the period, divided by weighted average number of shares outstanding - diluted.

Adjusted free cash flow is the Company’s net cash from operating activities, plus grants received, less net purchases of non-current assets (tangible and intangible).

Management believes these measures help illustrate underlying trends in the Company's business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing the Company's business and evaluating its performance. Management also believes the presentation of its non-IFRS financial measures enhances an investor’s overall understanding of the Company’s historical financial performance. The presentation of the Company’s non-IFRS financial measures is not meant to be considered in isolation or as a substitute for the Company’s financial results prepared in accordance with IFRS, and its non-IFRS measures may be different from non-IFRS measures used by other companies. Investors should review the reconciliation of the Company’s non-IFRS financial measures to the comparable IFRS financial measures included below, and not rely on any single financial measure to evaluate the Company’s business.

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” "outlook," “may,” “will”, and other similar terms and phrases. Such forward-looking statements include, but are not limited to, the statements regarding Endava’s projected financial performance for the third fiscal quarter of fiscal year 2021 and the full fiscal year 2021 and the challenges presented by the ongoing COVID-19 pandemic and the associated global economic uncertainty. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: Endava’s business, results of operations and financial condition may be negatively impacted by the COVID-19 pandemic and the precautions taken in response to the pandemic or if general economic conditions in Europe, the United States or the global economy worsen; Endava’s ability to manage its rapid growth or achieve anticipated growth; Endava’s ability to retain existing clients and attract new clients, including its ability to increase revenue from existing clients and diversify its revenue concentration; Endava’s ability to attract and retain highly-skilled IT professionals at cost-effective rates; Endava's ability to penetrate new industry verticals and geographies and grow its revenue in current industry verticals and geographies; Endava’s ability to maintain favourable pricing and utilisation rates; Endava’s ability to successfully identify acquisition targets, consummate acquisitions and successfully integrate acquired businesses and personnel; the effects of increased competition as well as innovations by new and existing competitors in its market; Endava’s ability to adapt to technological change and innovate solutions for its clients; Endava’s ability to collect on billed and unbilled receivables from clients; Endava’s ability to effectively manage its international operations, including Endava's exposure to foreign currency exchange rate fluctuations; Endava’s ability to remediate the identified material weaknesses and maintain an effective system of disclosure controls and internal control over financial reporting, and Endava’s future financial performance, including trends in revenue, cost of sales, gross profit, selling, general and administrative expenses, finance income and expense and taxes, as well as other risks and uncertainties discussed in the “Risk Factors” section of our Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on September 15, 2020. In addition, the forward-looking statements included in this press release represent Endava’s views and expectations as of the date hereof and are based on information currently available to Endava. Endava anticipates that subsequent events and developments may cause its views to change. Endava specifically disclaims any obligation to update the forward-looking statements in this press release except as required by law. These forward-looking statements should not be relied upon as representing Endava’s views as of any date subsequent to the date hereof.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

REVENUE

200,365

168,252

105,240

85,900

Cost of sales

 

 

 

 

Direct cost of sales

(120,479)

(122,592)

(63,003)

(73,828)

Allocated cost of sales

(9,912)

 

(8,311)

 

(5,180)

 

(4,391)

 

Total cost of sales

(130,391)

 

(130,903)

 

(68,183)

 

(78,219)

 

GROSS PROFIT

69,974

 

37,349

 

37,057

7,681

Selling, general and administrative expenses

(44,261)

 

(36,480)

 

(22,994)

 

(19,139)

 

OPERATING PROFIT/ (LOSS)

25,713

 

869

 

14,063

(11,458)

Net finance (expense) / income

(6,380)

 

(2,871)

 

(3,455)

 

(5,799)

 

Gain on sale of subsidiary

 

2,215

 

 

 

PROFIT/ (LOSS) BEFORE TAX

19,333

 

213

 

10,608

 

(17,257)

Tax on profit on ordinary activities

(4,826)

483

(2,809)

3,441

PROFIT/ (LOSS) FOR THE PERIOD

14,507

 

696

 

7,799

 

(13,816)

 

OTHER COMPREHENSIVE INCOME

 

 

 

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

Exchange differences on translating foreign operations

(3,491)

(4,385)

(2,644)

(2,460)

TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
ATTRIBUTABLE TO OWNERS OF THE PARENT

11,016

 

(3,689)

 

5,155

 

(16,276)

 

 

 

 

 

 

EARNINGS PER SHARE (EPS):

 

 

 

 

Weighted average number of shares outstanding - Basic

54,831,134

 

52,848,507

 

55,168,042

 

53,140,682

 

Weighted average number of shares outstanding - Diluted

56,850,290

 

55,663,120

 

57,107,940

 

55,957,472

 

Basic EPS (£)

0.26

0.01

0.14

 

(0.26)

 

Diluted EPS (£)

0.26

 

0.01

 

0.14

 

(0.25)

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

December 31, 2020

June 30, 2020

December 31, 2019

 

£’000

£’000

£’000
(Restated) (1)

ASSETS - NON-CURRENT

 

 

 

Goodwill

102,739

 

56,885

 

59,467

 

Intangible assets

34,961

 

38,751

 

31,478

 

Property, plant and equipment

11,985

 

12,747

 

11,776

 

Lease right-of-use assets

46,836

 

51,134

 

49,109

 

Financial assets

639

 

639

 

881

 

Deferred tax assets

13,552

 

13,340

 

11,447

 

TOTAL

210,712

 

173,496

 

164,158

 

ASSETS - CURRENT

 

 

 

Trade and other receivables

91,527

 

82,614

 

74,251

 

Corporation tax receivable

2,611

 

2,922

 

4,171

 

Financial assets

577

 

584

 

592

 

Cash and cash equivalents

84,221

 

101,327

 

78,975

 

TOTAL

178,936

 

187,447

 

157,989

 

TOTAL ASSETS

389,648

 

360,943

 

322,147

 

LIABILITIES - CURRENT

 

 

 

Lease liabilities

12,150

 

11,132

 

11,443

 

Trade and other payables

63,121

 

58,599

 

72,511

 

Corporation tax payable

1,865

 

1,449

 

983

 

Contingent consideration

1,091

 

1,442

 

1,131

 

Deferred consideration

2,786

 

3,764

 

1,707

 

TOTAL

81,013

 

76,386

 

87,775

 

LIABILITIES - NON CURRENT

 

 

 

Lease liabilities

39,141

 

42,233

 

39,545

 

Deferred tax liabilities

5,497

 

5,861

 

2,837

 

Deferred consideration

5,017

 

 

1,901

 

Other liabilities

138

 

136

 

108

 

TOTAL

49,793

 

48,230

 

44,391

 

EQUITY

 

 

 

Share capital

1,110

 

1,099

 

1,095

 

Share premium

230

 

221

 

137

 

Merger relief reserve

25,527

 

25,527

 

24,571

 

Retained earnings

239,469

 

214,638

 

156,313

 

Other reserves

(7,308)

 

(3,817)

 

9,548

 

Investment in own shares

(186)

 

(1,341)

 

(1,683)

 

TOTAL

258,842

 

236,327

 

189,981

 

TOTAL LIABILITIES AND EQUITY

389,648

 

360,943

 

322,147

 

1) The restatement refers to a reclassification of £20,141,000 from share premium to merger relief reserve.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

OPERATING ACTIVITIES

 

 

 

 

Profit/ (Loss) for the period

14,507

 

696

 

7,799

 

(13,816)

 

Income tax charge/ (credit)

4,826

 

(483)

 

2,809

 

(3,441)

 

Non-cash adjustments

27,486

 

15,886

 

15,069

 

13,930

 

Tax paid

(648)

 

(3,535)

 

(800)

 

(2,703)

 

UK research and development credit received

1,311

 

 

1,311

 

 

Net changes in working capital

(5,599)

 

13,936

 

(5,775)

 

17,121

 

Net cash from operating activities

41,883

 

26,500

 

20,413

 

11,091

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

Purchase of non-current assets (tangible and intangible)

(2,344)

 

(5,830)

 

(1,703)

 

(3,324)

 

Proceeds from disposal of non-current assets

108

 

120

 

43

 

107

 

Acquisition of business / subsidiaries (net of cash acquired)

(52,132)

 

(27,061)

 

(1,342)

 

(25,538)

 

Proceeds from sale of subsidiary net of cash disposed of

 

2,744

 

 

166

 

Cash and cash equivalents acquired with subsidiaries

1,603

 

3,289

 

 

3,289

 

Interest received

53

 

353

 

26

 

154

 

Net cash used in investing activities

(52,712)

 

(26,385)

 

(2,976)

 

(25,146)

 

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

Proceeds from sublease

289

 

302

 

132

 

148

 

Repayment of borrowings

 

(9)

 

 

 

Repayment of lease liabilities

(5,746)

 

(4,569)

 

(2,792)

 

(2,413)

 

Interest paid

(444)

 

(375)

 

(233)

 

(209)

 

Grant received / (repaid)

220

 

661

 

(89)

 

97

 

Proceeds from sale of EBT shares

 

14,797

 

 

14,797

 

Issue of shares

9

 

9

 

1

 

 

Net cash from financing activities

(5,672)

 

10,816

 

(2,981)

 

12,420

 

Net change in cash and cash equivalents

(16,501)

 

10,931

 

14,456

 

(1,635)

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

101,327

 

70,172

 

70,039

 

83,628

 

Exchange differences on cash and cash equivalents

(605)

 

(2,128)

 

(274)

 

(3,018)

 

Cash and cash equivalents at the end of the period

84,221

 

78,975

 

84,221

 

78,975

 

RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS FINANCIAL MEASURES

RECONCILIATION OF REVENUE GROWTH RATE AS REPORTED UNDER IFRS TO REVENUE GROWTH RATE AT CONSTANT CURRENCY:

 

Six Months ended
December 31

Three Months ended
December 31

 

2020

2019

2020

2019

REVENUE GROWTH RATE AS REPORTED UNDER IFRS

19.1

%

21.7

%

22.5

%

19.6

%

Foreign exchange rates impact

0.1

%

(0.7

%)

(1.1

%)

0.9

%

REVENUE GROWTH RATE AT CONSTANT CURRENCY
INCLUDING WORLDPAY CAPTIVE

19.2

%

21.0

%

21.4

%

20.5

%

Impact of Worldpay Captive

1.6

%

2.3

%

 

4.0

%

PRO-FORMA REVENUE GROWTH RATE AT CONSTANT
CURRENCY ADJUSTED FOR THE SALE OF THE WORLDPAY CAPTIVE

20.8

%

23.3

%

21.4

%

24.5

%

RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED PROFIT FOR THE PERIOD:

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX

19,333

 

213

 

10,608

 

(17,257)

 

Adjustments:

 

 

 

 

Share-based compensation expense

11,896

 

6,996

 

5,965

 

3,673

 

Discretionary EBT bonus

 

27,657

 

 

27,657

 

Amortisation of acquired intangible assets

2,280

 

1,809

 

1,114

 

913

 

Foreign currency exchange losses, net

5,304

 

2,913

 

2,892

 

5,466

 

Net gain on disposal of subsidiary

 

(2,215)

 

 

 

Total adjustments

19,480

 

37,160

 

9,971

 

37,709

 

ADJUSTED PROFIT BEFORE TAX

38,813

 

37,373

 

20,579

 

20,452

 

 

 

 

 

 

PROFIT/ (LOSS) FOR THE PERIOD

14,507

 

696

 

7,799

 

(13,816)

 

Adjustments:

 

 

 

 

Adjustments to profit before tax

19,480

 

37,160

 

9,971

 

37,709

 

Tax impact of adjustments

(2,966)

 

(7,508)

 

(1,416)

 

(7,115)

 

ADJUSTED PROFIT FOR THE PERIOD

31,021

 

30,348

 

16,354

 

16,778

 

 

 

 

 

 

Diluted EPS (£)

0.26

0.01

0.14

(0.25)

Adjusted diluted EPS (£)

0.55

0.55

0.29

0.30

RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Net cash from operating activities

41,883

 

26,500

 

20,413

 

11,091

 

Adjustments:

 

 

 

 

Grant received / (repaid)

220

 

661

 

(89)

 

97

 

Net purchases of non-current assets (tangible and intangible)

(2,236)

 

(5,710)

 

(1,660)

 

(3,217)

 

Adjusted Free cash flow

39,867

 

21,451

 

18,664

 

7,971

 

SUPPLEMENTARY INFORMATION

SHARE-BASED COMPENSATION EXPENSE

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Direct cost of sales

7,064

 

3,830

 

3,566

 

2,133

 

Selling, general and administrative expenses

4,832

 

3,166

 

2,399

 

1,540

 

Total

11,896

 

6,996

 

5,965

 

3,673

 

DEPRECIATION AND AMORTISATION

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Direct cost of sales

7,863

 

5,910

 

4,293

 

3,159

 

Selling, general and administrative expenses

3,568

 

2,833

 

1,795

 

1,457

 

Total

11,431

 

8,743

 

6,088

 

4,616

 

EMPLOYEE BENEFIT TRUST DISCRETIONARY BONUS

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Direct cost of sales

 

25,182

 

 

25,182

 

Selling, general and administrative expenses

 

2,475

 

 

2,475

 

Total

 

27,657

 

 

27,657

 

EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT

Six Months Ended
December 31

Three Months Ended
December 31

 

2020

2019

2020

2019

 

 

 

 

 

Closing number of total employees (including directors)

7,464

6,267

7,464

6,267

Average operational employees

6,417

5,405

6,629

5,472

 

 

 

 

 

Top 10 customers %

38%

39%

37%

37%

Number of clients with > £1m of revenue
(rolling 12 months)

75

65

75

65

 

 

 

 

 

Geographic split of revenue %

 

 

 

 

North America

29%

28%

29%

29%

Europe

26%

24%

27%

23%

UK

43%

46%

42%

45%

Rest of World (RoW)

2%

2%

2%

3%

Industry vertical split of revenue %

 

 

 

 

Payments and Financial Services

50%

53%

49%

53%

TMT

28%

25%

28%

24%

Other

22%

22%

23%

23%

 

FAQ

What were Endava's Q2 FY2021 earnings results?

Endava reported Q2 FY2021 revenue of £105.2 million, a 22.5% increase year-on-year, with a profit before tax of £10.6 million.

What is Endava's guidance for Q3 FY2021?

Endava expects Q3 FY2021 revenues between £110.0 million and £111.5 million, indicating constant currency growth of 20.0% to 21.5%.

How did Endava perform in the previous year?

In Q2 FY2020, Endava had a loss before tax of £(17.3) million due to a non-recurring bonus, while this year it achieved a profit.

What is Endava's full fiscal year 2021 revenue guidance?

For the full fiscal year 2021, Endava expects revenues between £423.0 million and £426.0 million.

What were the adjusted EPS figures for Q2 FY2021?

Endava reported an adjusted diluted EPS of £0.29 for Q2 FY2021, down from £0.30 in the prior year.

Endava plc American Depositary Shares (each representing one

NYSE:DAVA

DAVA Rankings

DAVA Latest News

DAVA Stock Data

1.69B
59.20M
0.57%
81.09%
1.91%
Software - Infrastructure
Technology
Link
United States of America
London